Product pipeline

           For RNA helicase family proteins,  currently there are eIF4A inhibitors in the phase I/II of clinical trials abroad. Multiple helicase family member proteins such as DDX3X, DDX5, and DHX9 are highly expressed in various human cancers, and inhibitors targeting these proteins are currently in the preclinical research stage. KeYe Life has developed several unique RNA helicase family members as novel cancer treatment targets. we are playing a leading role in developing these drugs internationally.

Core technology